-
公开(公告)号:WO2021248093A1
公开(公告)日:2021-12-09
申请号:PCT/US2021/036038
申请日:2021-06-04
IPC分类号: A61K31/4178 , A61K31/4166 , A61K45/06 , A61P35/00
摘要: The present invention discloses daclatasvir (DCV) for use in the treatment and/or prevention of cancer, preferably lung cancer and/ or prostate cancer, more preferably enzalutamide-resistant prostate cancer.